Literature DB >> 7396076

Roles of lithogenic bile and cystic duct occlusion in the pathogenesis of acute cholecystitis.

J J Roslyn, L DenBesten, J E Thompson, B F Silverman.   

Abstract

The hypothesis that the elements essential for the induction of acute cholecystitis are the presence of lithogenic bile and cystic duct occlusion was tested in the prairie dog gallstone model. Neither the presence of gallstones alone nor acute cystic duct occlusion alone resulted in acute inflammation of the gallbladder. Acute cholecystitis developed in prairie dog gallbladders containing cholesterol-saturated bile, with or without gallstones, shortly after cystic duct occlusion. These data suggest that the factors essential for the induction of acute cholecystitis are the presence of lithogenic bile and cystic duct occlusion and that gallstones, although frequently present, are not an essential prerequisite to acute inflammation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7396076     DOI: 10.1016/0002-9610(80)90428-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  13 in total

1.  Risk factors of acute cholecystitis after endoscopic common bile duct stone removal.

Authors:  Jun Kyu Lee; Ji Kon Ryu; Joo Kyung Park; Won Jae Yoon; Sang Hyub Lee; Kwang Hyuck Lee; Yong-Tae Kim; Yong Bum Yoon
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

2.  Natural Course of Acute Cholecystitis in Patients Treated With Percutaneous Transhepatic Gallbladder Drainage Without Elective Cholecystectomy.

Authors:  Yu-Liang Hung; Sio-Wai Chong; Chi-Tung Cheng; Chien-Hung Liao; Chih-Yuan Fu; Chi-Hsun Hsieh; Ta-Sen Yeh; Chun-Nan Yeh; Yi-Yin Jan; Shang-Yu Wang
Journal:  J Gastrointest Surg       Date:  2019-04-03       Impact factor: 3.452

3.  Effect of experimental acalculous cholecystitis on gallbladder smooth muscle contractility.

Authors:  H P Parkman; L J Bogar; L L Bartula; A P Pagano; R M Thomas; S I Myers
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

4.  Outcome after percutaneous cholecystostomy for acute cholecystitis: a single-center experience.

Authors:  Yun-Cheng Hsieh; Chun-Ku Chen; Chien-Wei Su; Che-Chang Chan; Teh-Ia Huo; Chia-Jen Liu; Wen-Liang Fang; Kuei-Chuan Lee; Han-Chieh Lin
Journal:  J Gastrointest Surg       Date:  2012-07-25       Impact factor: 3.452

5.  Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones.

Authors:  Michele Pier Luca Guarino; Ping Cong; Michele Cicala; Rossana Alloni; Simone Carotti; Jose Behar
Journal:  Gut       Date:  2006-12-21       Impact factor: 23.059

6.  Possible mortality reduction by endoscopic sphincterotomy during endoscopic retrograde cholangiopancreatography: a population-based case-control study.

Authors:  Cecilia Strömberg; Urban Arnelo; Lars Enochsson; Matthias Löhr; Magnus Nilsson
Journal:  Surg Endosc       Date:  2011-11-15       Impact factor: 4.584

7.  Altered gallbladder concentration of biliary lipids during early cholesterol gallstone formation.

Authors:  J J Roslyn; R L Conter; L DenBesten
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

8.  Endoscopically obtained bile aspirate is an accurate adjunct in the diagnosis of symptomatic gallbladder disease.

Authors:  Kerrey B Buser
Journal:  JSLS       Date:  2010 Oct-Dec       Impact factor: 2.172

9.  Acute Reactive Acalculous Cholecystitis Secondary to Duodenal Ulcer Perforation.

Authors:  Shab E Gul Rahim; Mohammad Alomari; Shrouq Khazaaleh; Ahmed Alomari; Laith A Al Momani
Journal:  Cureus       Date:  2019-03-27

10.  Long-Term Outcomes of Patients with Acute Cholecystitis after Successful Percutaneous Cholecystostomy Treatment and the Risk Factors for Recurrence: A Decade Experience at a Single Center.

Authors:  Chih-Hung Wang; Cheng-Yi Wu; Justin Cheng-Ta Yang; Wan-Ching Lien; Hsiu-Po Wang; Kao-Lang Liu; Yao-Ming Wu; Shyr-Chyr Chen
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.